The distribution and storage of vaccines is a real headache.
Both because of the low temperature at which those of Pfizer-BioNTech (- 70 ° C) and Moderna (- 20 ° C) must be kept, and the enormous volumes required or the diversity of the audiences concerned.
Several unknowns remain for the vaccination of residents of nursing homes and at-risk staff who work there and will be the first to be vaccinated, perhaps as early as January.
Starting with the number of vaccines that will have received the green light from the European Commission in time, a prerequisite for the delivery of the first doses.
The first three laboratories to have published their preliminary results, will Pfizer-BioNTech, Moderna and AstraZeneca-Oxford all be there?
"Moderna's vaccine may be available in France in December if approved by the European regulatory authorities,"
assures Stéphane Bancel who filed his request for provisional authorization on Monday.
This article is for subscribers only.
You have 80% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in